MAPT and Alzheimer disease: Chenglong Xie [142] used computer-aided drug screening technology to identify 18 small molecules that can act as mitochondrial autophagy inducers, increasing the survival and function of glutamate and acetylcholine neurons, eliminating amyloid-β and tau pathology, and improving the pathological symptoms of AD.